Exane Derivatives’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Exane Derivatives’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$525	Hold	7	–	–	﹤0.01%	565
2022 Q1	$557	Hold	7	–	–	﹤0.01%	849
2021 Q4	$568	Hold	7	–	–	﹤0.01%	758
2021 Q3	$542	Hold	7	–	–	﹤0.01%	930
2021 Q2	$559	Hold	7	–	–	﹤0.01%	932
2021 Q1	$552	Hold	7	–	–	﹤0.01%	789
2020 Q4	$500	Hold	7	–	–	﹤0.01%	741
2020 Q3	$447	Hold	7	–	–	﹤0.01%	687
2020 Q2	$453	Hold	7	–	–	﹤0.01%	620
2020 Q1	$385	Hold	7	–	–	﹤0.01%	622
2019 Q4	$462	Hold	7	–	–	﹤0.01%	618
2019 Q3	$397	Hold	7	–	–	﹤0.01%	598
2019 Q2	$421	Hold	7	–	–	﹤0.01%	605
2019 Q1	$456	Sell	7 -114	-94%	-$7.49K	﹤0.01%	545
2018 Q4	$7.54K	Sell	121 -4,120	-97%	-$278K	﹤0.01%	475
2018 Q3	$312K	Buy	+4,241	New	+$304K	0.06%	198
2018 Q2	–	Sell	-1,617	Closed	-$99.7K	–	698
2018 Q1	$99.7K	Sell	1,617 -1,431	-47%	-$94.2K	0.02%	301
2017 Q4	$196K	Buy	3,048 +515	+20%	+$33K	0.03%	239
2017 Q3	$166K	Buy	2,533 +740	+41%	+$46.7K	0.03%	209
2017 Q2	$113K	Buy	+1,793	New	+$108K	0.02%	263
2017 Q1	–	Sell	-887	Closed	-$49.7K	–	641
2016 Q4	$49.7K	Sell	887 -735	-45%	-$42.3K	0.01%	298
2016 Q3	$100K	Buy	1,622 +73	+5%	+$4.78K	0.02%	245
2016 Q2	$98.1K	Buy	1,549 +396	+34%	+$24.9K	0.02%	243
2016 Q1	$69.3K	Sell	1,153 -132	-10%	-$8.07K	0.01%	273
2015 Q4	$89.9K	Buy	+1,285	New	+$91.1K	0.01%	218

Other funds holding PJP

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

DBIA

Dumont & Blake Investment Advisors Princeton, New Jersey $445M AUM 31.98% 1-Year Est. Return

Exane Derivatives's PJP Position: Q2 2022 in Review

Exane Derivatives held its Invesco Pharmaceuticals ETF (PJP) position steady in Q2 2022 at 7 shares worth $525. The position accounts for ﹤0.01% of the portfolio, ranked #565.

Exane Derivatives first reported a position in PJP in Q4 2015 and has held it in 25 quarters since. The position peaked at $312K in Q3 2018. 79 funds tracked by Wall St. Rank hold PJP as of Q2 2022.

Exane Derivatives held 7 shares of Invesco Pharmaceuticals ETF worth $525 as of Q2 2022.
Exane Derivatives left its Invesco Pharmaceuticals ETF share count unchanged in Q2 2022.
Invesco Pharmaceuticals ETF made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #565 holding.
Exane Derivatives first reported a position in Invesco Pharmaceuticals ETF in Q4 2015 and has held it in 25 quarters since.
Exane Derivatives's Invesco Pharmaceuticals ETF position peaked at $312K in Q3 2018.
79 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.